Publicaciones en colaboración con investigadores/as de University of Cologne (9)

2024

  1. Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis

    Science Advances , Vol. 10, Núm. 42

2020

  1. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

    The Lancet Neurology, Vol. 19, Núm. 11, pp. 951-962

2017

  1. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 3, (353-357), 10.1007/s00259-016-3589-9)

    European Journal of Nuclear Medicine and Molecular Imaging

  2. The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis

    European Journal of Nuclear Medicine and Molecular Imaging

  3. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy

    NeuroImage: Clinical, Vol. 13, pp. 386-394

2016

  1. Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity

    Cell, Vol. 165, Núm. 4, pp. 882-895

  2. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

    Neuro-Oncology, Vol. 18, Núm. 9, pp. 1199-1208

2015

  1. A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives

    European Journal of Nuclear Medicine and Molecular Imaging

2014

  1. The paradox of neuronal insulin action and resistance in the development of aging-associated diseases

    Alzheimer's and Dementia, Vol. 10, Núm. 1 SUPPL., pp. S3